US Patent Issued to Amgen on June 2 for "Mcl-1 inhibitor formulations" (California, Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,913, issued on June 2, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Mcl-1 inhibitor formulations" was invented by James E. Huckle (Moorpark, Calif.), Markian M. Stec (Moorpark, Calif.), Tian Wu (Newbury Park, Calif.), Darren L Reid (Belmont, Mass.), Fernando A. Alvarez-Nunez (Newbury Park, Calif.) and Sean P. Brown (Half Moon Bay, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are solid dispersions comprising AMG 397, methods of preparing the solid dispersion, and pharmaceutical formulations comprising AMG 397."

The patent was filed on Aug. 24, 2021, under Application No. 18/022,905.

*For further information, includin...